bendamustine hydrochloride has been researched along with Carcinoma, Neuroendocrine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chinnaiyan, P; Neuger, A; Pan, E; Smith, P; Yu, D; Yu, HH; Zhao, X | 1 |
1 trial(s) available for bendamustine hydrochloride and Carcinoma, Neuroendocrine
| Article | Year |
|---|---|
Phase I study of bendamustine with concurrent whole brain radiation therapy in patients with brain metastases from solid tumors.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Brain Neoplasms; Breast Neoplasms; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Combined Modality Therapy; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Nitrogen Mustard Compounds; Survival Analysis; Treatment Outcome | 2014 |